Several researches indicate that the decrease in NOX1 expression in urothelial carcinoma results in a decline in the generation of reactive oxygen species (ROS) and a resistance to programmed cell death, ultimately contributing to the progression of bladder cancer [29]. The gene discussed is NOX1; the disease is urinary bladder cancer.